DEERFIELD MANAGEMENT COMPANY, L.P.
New York, NY · CIK 1009258 · 13F filing filed 2022-05-16
SEC-registered investment adviser since 2012 · limited partnership
- Assets managed$19.1bn
- Staff189 · 89 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds12 (11 hedge) · $19.2bn gross assets
- Form ADV · 2026-07-31SEC adviser record
- Legal entityDEERFIELD MANAGEMENT COMPANY, L.P. (US)
- Kindhedge funds, private equity, futures
- Others nearbyNew York, NY, Parsippany, NJ
As an employer
- Offices in1 country
- Private fundshedge 11, private equity 1
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 86 |
| Parsippany, NJUnited States | 3 |
US visa salary filings
- Filings FY2024–20266
- Median salary offered$160,000
- Middle half$140,000 – $191,250
- Job titles5
| Job title | Filings | Median |
|---|---|---|
| AnalystNew York, NY | 2 | $140,000 |
| Data EngineerNew York, NY | 1 | $210,000 |
| Senior Director, Business IntelligenceNew York, NY | 1 | $195,000 |
| Director, Business IntelligenceNew York, NY | 1 | $180,000 |
| Market Research AssociateNew York, NY | 1 | $80,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Deerfield Management Company, L.P..
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 1 call positions ($2.6m notional), 0 put positions (— notional) – listed below, not included above.
This report includes the holdings of 1 other manager that shares the investment decisions:
- Flynn Management LLC – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q1 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| GLAUKOS CORP GKOS 2.75 06.15.27 · principal | $358.8m8.03% | Added +65.2m |
| NUVALENT INC COM | $268.6m6.01% | Unchanged |
| VIATRIS INC VTRS | $224.9m5.03% | Reduced -100.3k |
| ADAPTHEALTH CORP AHCO | $186.8m4.18% | Added +1.4m |
| INVITAE CORP NVTA 2 09.01.24 · principal | $169.8m3.80% | Added +43.5m |
| NEUROCRINE BIOSCIENCES INC NBIX | $155.4m3.48% | Added +279.9k |
| AERIE PHARMACEUTICALS INC AERI 1.5 10.01.24 · principal | $141.9m3.17% | Unchanged |
| ENVISTA HOLDINGS CORPORATION NVST 2.375 06.01.25 · principal | $123.9m2.77% | Unchanged |
| CAREMAX INC COM CL A | $121.8m2.72% | Reduced -917.7k |
| NATERA INC NTRA 2.25 05.01.27 · principal | $120.2m2.69% | Added +45.6m |
| SAREPTA THERAPEUTICS INC SRPT 1.5 11.15.24 | $116.1m2.60% | New |
| PACIRA BIOSCIENCES INC PCRX 0.75 08.01.25 · principal | $100.9m2.26% | Unchanged |
| NUVASIVE INC GMED 1 06.01.23 · principal | $96.4m2.16% | Unchanged |
| PULMONX CORP LUNG | $91.7m2.05% | Added +1.3m |
| SILK RD MED INC SILK | $88.9m1.99% | Added +636.5k |
| IVERIC BIO INC OPHT | $82.3m1.84% | Added +130.9k |
| APELLIS PHARMACEUTICALS INC APLS 3.5 09.15.26 · principal | $81.7m1.83% | Added +23.1m |
| TABULA RASA HEALTHCARE INC TRHC 1.75 02.15.26 · principal | $79.7m1.78% | Added +10.0m |
| INSULET CORP PODD 0.375 09.01.26 · principal | $76.2m1.71% | Unchanged |
| NUVASIVE INC GMED 0.375 03.15.25 · principal | $76.1m1.70% | Added +2.1m |
| INSMED INC INSM 1.75 01.15.25 · principal | $74.9m1.68% | Added +25.0m |
| MIRUM PHARMACEUTICALS INC MIRM | $72.3m1.62% | Unchanged |
| KURA ONCOLOGY INC KURA | $71.0m1.59% | Added +902.6k |
| NEVRO CORP NVRO 2.75 04.01.25 · principal | $65.4m1.46% | Unchanged |
| ORGANOGENESIS HLDGS INC ORGO | $64.4m1.44% | Unchanged |
| INTERCEPT PHARMACEUTICALS IN ICPT 3.25 07.01.23 · principal | $53.0m1.19% | Unchanged |
| DECIPHERA PHARMACEUTICALS IN DCPH | $51.7m1.16% | Unchanged |
| HORIZON THERAPEUTICS PUB L HZNP | $48.9m1.09% | New |
| BRIDGEBIO PHARMA INC BBIO 2.5 03.15.27 · principal | $47.4m1.06% | Unchanged |
| CENTENE CORP DEL CNC | $46.6m1.04% | Reduced -450.0k |
| GILEAD SCIENCES INC GILD | $45.5m1.02% | New |
| MOLINA HEALTHCARE INC MOH | $45.0m1.01% | Unchanged |
| AERIE PHARMACEUTICALS INC AERI | $42.7m0.96% | Unchanged |
| SEMA4 HOLDINGS CORP SMFR | $42.5m0.95% | Reduced -118.3k |
| SINGULAR GENOMICS SYSTEMS IN COM | $41.7m0.93% | Reduced -2.5m |
| ALPHATEC HLDGS INC ATEC | $41.3m0.92% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $38.2m0.85% | Unchanged |
| BROOKDALE SR LIVING INC BKD | $37.9m0.85% | Added +1.1m |
| CYTOKINETICS INC CYTK | $35.1m0.78% | Added +143.7k |
| 1LIFE HEALTHCARE INC ONEM 3 06.15.25 · principal | $34.7m0.78% | New |
| THE ONCOLOGY INSTITUTE INC STLN | $32.1m0.72% | Unchanged |
| PHARVARIS N V PHVS | $28.6m0.64% | Reduced -4.3k |
| NOVAVAX INC NVAX 3.75 02.01.23 · principal | $26.8m0.60% | Unchanged |
| BELLUS HEALTH INC NEW BLU | $25.3m0.57% | Added +1.2m |
| LARIMAR THERAPEUTICS INC LRMR | $23.6m0.53% | Unchanged |
| REVOLUTION MEDICINES INC RVMD | $22.7m0.51% | Unchanged |
| MIRATI THERAPEUTICS INC MRTX | $22.2m0.50% | Added +182.0k |
| GLAUKOS CORP GKOS | $21.4m0.48% | Reduced -791.9k |
| XERIS PHARMACEUTICALS INC XERS 5 07.15.25 · principal | $21.1m0.47% | Unchanged |
| DAY ONE BIOPHARMACEUTICALS I COM | $20.7m0.46% | Reduced -116.1k |
| GOODRX HLDGS INC GDRX | $18.9m0.42% | New |
| NUVATION BIO INC NUVB | $18.8m0.42% | Unchanged |
| OUTSET MED INC OM | $18.2m0.41% | Unchanged |
| HEALTH CATALYST INC HCAT 2.5 04.15.25 · principal | $17.2m0.38% | Unchanged |
| IMMUNOGEN INC IMGN | $16.5m0.37% | New |
| BIOCRYST PHARMACEUTICALS INC BCRX | $16.5m0.37% | Reduced -674.1k |
| DA32 LIFE SCNCE TEC ACQSTN C CLASS A COM | $15.5m0.35% | Unchanged |
| PROFOUND MED CORP PROF | $15.4m0.35% | Unchanged |
| PTC THERAPEUTICS INC PTCT 3 08.15.22 · principal | $15.1m0.34% | Unchanged |
| ALECTOR INC ALEC | $15.0m0.34% | Unchanged |
| XILIO THERAPEUTICS INC COM | $14.7m0.33% | Reduced -75.4k |
| OAK STR HEALTH INC OSH 0 03.15.26 · principal | $14.3m0.32% | New |
| SPRINGWORKS THERAPEUTICS INC SWTX | $14.1m0.32% | Reduced -202.0k |
| EVOLUS INC EOLS | $13.8m0.31% | New |
| KALVISTA PHARMACEUTICALS INC KALV | $12.2m0.27% | Reduced -344.7k |
| COGENT BIOSCIENCES INC COGT | $12.0m0.27% | Unchanged |
| MERUS N V MRUS | $11.6m0.26% | Unchanged |
| KINNATE BIOPHARMA INC KNTE | $11.1m0.25% | Unchanged |
| APOLLO ENDOSURGERY INC COM | $10.6m0.24% | Unchanged |
| SARISSA CAPITAL ACQUISITN CO CL A | $9.9m0.22% | Unchanged |
| EUCRATES BIOMEDICAL ACQU COR SHS | $9.8m0.22% | Unchanged |
| SENIOR CONNECT ACQUISITN COR COM CL A | $9.8m0.22% | Unchanged |
| REVOLUTION HEALTHCAR AQ CORP CLASS A COM | $9.8m0.22% | Unchanged |
| MEDTECH ACQUISITION CORP COM CL A | $9.8m0.22% | Unchanged |
| INOZYME PHARMA INC COM | $9.6m0.21% | Unchanged |
| AN2 THERAPEUTICS INC ANTX | $8.8m0.20% | New |
| NYXOAH S A NYXH | $8.7m0.19% | Unchanged |
| TURMERIC ACQUISITION CORP CL A | $7.4m0.17% | Unchanged |
| INSMED INC INSM | $7.2m0.16% | New |
| IGNYTE ACQUISITION CORP COM | $7.1m0.16% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $7.0m0.16% | Unchanged |
| QUANTUM SI INC QSI | $6.6m0.15% | Unchanged |
| GRAYBUG VISION INC COM SHS | $6.5m0.15% | Unchanged |
| BENEFITFOCUS INC BNFT 1.25 12.15.23 | $6.3m0.14% | Unchanged |
| ONCORUS INC COM | $5.6m0.13% | Unchanged |
| VINCERX PHARMA INC COM NEW | $5.5m0.12% | Unchanged |
| ORCHARD THERAPEUTICS PLC ORTX | $4.9m0.11% | Unchanged |
| ORION ACQUISITION CORP COM CL A | $4.9m0.11% | Unchanged |
| WEREWOLF THERAPEUTICS INC HOWL | $4.2m0.09% | Unchanged |
| CULLINAN THERAPEUTICS INC CGEM | $3.9m0.09% | Reduced -296.1k |
| ACUTUS MED INC AFIB | $3.7m0.08% | Unchanged |
| FOGHORN THERAPEUTICS INC FHTX | $3.6m0.08% | New |
| RHYTHM PHARMACEUTICALS INC RYTM | $3.4m0.07% | Reduced -1.6m |
| DELCATH SYS INC DCTH | $3.2m0.07% | Unchanged |
| NEOGENOMICS INC NEO 0.25 01.15.28 · principal | $1.7m0.04% | Unchanged |
| AMERICAN WELL CORP CL A | $1.6m0.04% | Reduced -600.0k |
| ANNEXON INC ANNX | $1.6m0.04% | Unchanged |
| BIOATLA INC BCAB | $1.4m0.03% | Unchanged |
| THE ONCOLOGY INSTITUTE INC STLNW | $1.4m0.03% | Unchanged |
| CAREMAX INC *W EXP 06/08/202 | $1.3m0.03% | Unchanged |
Sold out since Q4 2021
| Security | Value then |
|---|---|
| APRIA INC | $54.0m1.7m shares |
| PROTAGONIST THERAPEUTICS INC PTGX | $40.1m1.2m shares |
| PACIRA BIOSCIENCES INC PCRX | $35.9m596.3k shares |
| ESPERION THERAPEUTICS INC NE ESPR | $25.0m5.0m shares |
| MERIDIAN BIOSCIENCE INC VIVO | $23.0m1.1m shares |
| FIGS INC FIGS | $22.9m829.7k shares |
| NEVRO CORP NVRO | $17.5m216.0k shares |
| APELLIS PHARMACEUTICALS INC APLS | $16.2m343.2k shares |
| SAREPTA THERAPEUTICS INC SRPT | $12.7m141.0k shares |
| BLUEPRINT MEDICINES CORP BPMC | $11.8m110.0k shares |
| LIANBIO LIANY | $11.0m1.8m shares |
| WEAVE COMMUNICATIONS INC WEAV | $8.4m554.5k shares |
| GUARDANT HEALTH INC GH 0 11.15.27 | $8.1m8.0m shares |
| PRIVIA HEALTH GROUP INC PRVA | $7.8m300.0k shares |
| HYPERFINE INC HYPR | $7.2m1.0m shares |
| DEFINITIVE HEALTHCARE CORP DH | $6.8m250.0k shares |
| PYXIS ONCOLOGY INC PYXS | $3.4m311.8k shares |
| WAVE LIFE SCIENCES LTD 96663EUR | $1.7m552.7k shares |
| BIODELIVERY SCIENCES INTL IN BDSI | $91.0k29.2k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| GLAUKOS CORP GKOS · Call | $2.6m45.2k shares | Unchanged |